Recombinant TIGIT (Domvanalimab Biosimilar) antibody

Catalog No. ABIN7675939

The Human Monoclonal anti-TIGIT (Domvanalimab Biosimilar) antibody (ABIN7675939) specifically detects TIGIT (Domvanalimab Biosimilar) in BLI, ELISA, FACS, Func and SPR. The antibody is reactive with Human samples.

Quick Overview for Recombinant TIGIT (Domvanalimab Biosimilar) antibody (ABIN7675939)

Target: TIGIT (Domvanalimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TIGIT (Domvanalimab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-TIGIT (Domvanalimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-TIGIT Reference Antibody (domvanalimab)

Characteristics: Anti-TIGIT Reference Antibody (domvanalimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for TIGIT (Domvanalimab Biosimilar)

Target: TIGIT (Domvanalimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q495A1